Promoter and use thereof

US10501745B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10501745-B2
Application numberUS-201615563750-A
CountryUS
Kind codeB2
Filing dateMar 11, 2016
Priority dateApr 2, 2015
Publication dateDec 10, 2019
Grant dateDec 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to a novel promoter, a vector comprising the promoter, a microorganism comprising the vector, and a method for producing a target protein using the promoter.

First claim

Opening claim text (preview).

The invention claimed is: 1. An isolated nucleic acid molecule having a promoter activity, wherein the isolated nucleic acid molecule comprises the nucleotide sequence of SEQ ID NO: 1. 2. A target protein expression cassette comprising the isolated nucleic acid molecule having a promoter activity of claim 1 and a gene encoding a target protein. 3. A recombinant vector comprising the isolated nucleic acid molecule of claim 1 or the target protein expression cassette of claim 2 . 4. The recombinant vector of claim 3 , wherein the target protein is a psicose-3-epimeras. 5. A method for producing psicose, comprising: (a) culturing the microorganism introduced with the vector of claim 4 ; and (b) reacting the cultured microorganism with fructose to produce psicose. 6. A recombinant microorganism introduced with the vector of claim 4 . 7. The recombinant microorganism of claim 6 , wherein the microorganism is a microorganism of the genus Corynebacterium. 8. The recombinant microorganism of claim 7 , wherein the microorganism of the genus Corynebacterium is Corynebacterium glutamicum or Corynebacterium ammoniagenes. 9. The recombinant microorganism of claim 6 , wherein the microorganism is a microorganism of the genus Escherichia. 10. The recombinant microorganism of claim 9 , wherein the microorganism of the genus Escherichia is Escherichia coli. 11. A method for producing a target protein, comprising: (a) culturing the recombinant microorganism of claim 6 in a medium to produce a target protein; and (b) recovering the produced target protein from the cultured microorganism or the medium. 12. A recombinant microorganism introduced with the vector of claim 3 . 13. The recombinant microorganism of claim 12 , wherein the microorganism is a microorganism of the genus Corynebacterium. 14. The recombinant microorganism of claim 13 , wherein the microorganism of the genus Corynebacterium is Corynebacterium glutamicum or Corynebacterium ammoniagenes. 15. The recombinant microorganism of claim 12 , wherein the microorganism is a microorganism of the genus Escherichia. 16. The recombinant microorganism of claim 15 , wherein the microorganism of the genus Escherichia is Escherichia coli. 17. A method for producing a target protein, comprising: (a) culturing the recombinant microorganism of claim 12 in a medium to produce the target protein; and (b) recovering the produced target protein from the cultured microorganism or the medium.

Assignees

Inventors

Classifications

  • C12P21/02Primary

    having a known sequence of two or more amino acids, e.g. glutathione · CPC title

  • C12N15/70Primary

    Vectors or expression systems specially adapted for E. coli · CPC title

  • Preparation of peptides or proteins (single cell protein C12N1/00) · CPC title

  • Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

  • C12N15/113Primary

    Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10501745B2 cover?
The present disclosure relates to a novel promoter, a vector comprising the promoter, a microorganism comprising the vector, and a method for producing a target protein using the promoter.
Who is the assignee on this patent?
Cj Cheiljedang Corp
What technology area does this patent fall under?
Primary CPC classification C12P21/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).